Prosecution Insights
Last updated: April 19, 2026

Novadip Biosciences

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18037630 CELLULAR AND/OR EXTRACELLULAR EXTRACTS FOR PREVENTING AND/OR TREATING CANCER AND/OR INFLAMMATION FIEBIG, RUSSELL G 1655 Final Rejection May 18, 2023
17781158 Biomaterials for the prevention and the treatment of tissue disorders GOTFREDSON, GAREN 1619 Final Rejection May 31, 2022
17273143 BIOMATERIAL COMPRISING ADIPOSE-DERIVED STEM CELLS AND GELATIN AND METHOD FOR PRODUCING THE SAME TRAN, KHOA NHAT 1632 Non-Final OA Mar 03, 2021
16646754 BIOMATERIAL COMPRISING ADIPOSE-DERIVED STEM CELLS AND METHOD FOR PRODUCING THE SAME ARNOLD, ERNST V 1613 Non-Final OA Mar 12, 2020

Managing Novadip Biosciences's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month